InvestorsHub Logo
Followers 4
Posts 1198
Boards Moderated 0
Alias Born 10/03/2015

Re: DewDiligence post# 1235

Monday, 12/21/2015 11:34:36 AM

Monday, December 21, 2015 11:34:36 AM

Post# of 3021
The implication from Medivir’s PR is that JNJ’s HCV program, if not dead, is on life support. JNJ still has the HCV compounds acquired from ACHN, but without the Alios nuke [AL-704] it’s hard to see a viable business plan here.

Are AL-335 and AL-516 backups?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News